v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Net sales $ 1,715.5 $ 1,553.1 $ 5,105.1 $ 4,498.0
Cost of sales 369.2 345.2 1,124.2 991.2
Gross profit 1,346.3 1,207.9 3,980.9 3,506.8
Selling, general, and administrative expenses 560.9 514.6 1,644.3 1,482.3
Research and development expenses 281.4 280.7 823.6 811.5
Certain litigation (insurance recovery) expenses, net (12.7) 90.4 30.7 116.8
Change in fair value of contingent consideration liabilities 0.0 (12.5) 0.0 (12.5)
Restructuring charges, separation costs, and other (Note 3) 10.7 0.1 10.7 8.5
Impairment of intangible and long-lived assets (Note 2) 220.2 40.0 220.2 40.0
Other operating income (13.3) (12.5) (38.5) (52.9)
Operating income, net 299.1 307.1 1,289.9 1,113.1
Interest income, net (36.5) (38.6) (100.0) (112.5)
Loss on impairment (Note 6) 0.0 0.0 163.6 47.1
Other non-operating income, net (Note 7) (27.6) (2.7) (115.7) (4.0)
Income from continuing operations before provision for income taxes 363.2 348.4 1,342.0 1,182.5
Provision for income taxes 61.8 56.1 418.5 190.7
Net income from continuing operations 301.4 292.3 923.5 991.8
Loss from discontinued operations, net of tax 0.0 (2.0) 0.0 (13.6)
Net income 301.4 290.3 923.5 978.2
Less: Net loss attributable to noncontrolling interest (6.1) (0.8) (6.6) (4.1)
Net income attributable to Edwards Lifesciences Corporation $ 307.5 $ 291.1 $ 930.1 $ 982.3
Basic        
Continuing operations (in dollars per share) $ 0.53 $ 0.50 $ 1.61 $ 1.70
Discontinued operations (in dollars per share) 0 0 0 (0.02)
Basic earnings per share (in dollars per share) 0.53 0.50 1.61 1.68
Diluted        
Continuing operations (in dollars per share) 0.53 0.50 1.61 1.70
Discontinued operations (in dollars per share) 0 0 0 (0.03)
Diluted earnings per share (in dollars per share) $ 0.53 $ 0.50 $ 1.61 $ 1.67
Weighted-average number of common shares outstanding:        
Basic (in shares) 576.3 584.7 577.3 586.2
Diluted (in shares) 577.6 585.7 578.6 587.2